GENOVIS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30 SEK | -2.91% |
|
-17.70% | -42.31% |
| May. 15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOVIS AB | Diagnostic & Testing Substances | -2.91% | -17.70% | -42.31% | -42.86% | +59.15% | 193M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- GENO Stock
- Charts Genovis AB
- Comparison Chart
